Yasuo Iwamoto

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105

Nobuyuki Yamamoto, Kazuhiko Nakagawa, Yasumasa Nishimura et al. · Journal of Clinical Oncology · 2010 · 304 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Prevalence, Concomitance, and Distribution of Ossification of the Spinal Ligaments

Takahito Fujimori, Tadashi Watabe, Yasuo Iwamoto et al. · Spine · 2016 · 210 citations

Medicine, Orthopedic Surgery, Radiology +13

Endobronchial Ultrasonography in the Assessment of Centrally Located Early-Stage Lung Cancer before Photodynamic Therapy

Yuka Miyazu, Teruomi Miyazawa, Noriaki Kurimoto et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 208 citations

Medicine, Oncology, Diagnostic Imaging +15

Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203)

Koji Takeda, Toyoaki Hida, Tosiya Sato et al. · Journal of Clinical Oncology · 2009 · 170 citations · Full text

Medicine, Oncology, Pharmacology +15